Loading
institutionsInstitution
CeCurio (MVZ Tübingen oncology)
CeCurio, the oncology and haematology practice of MVZ Tübingen, offers personalised peptide vaccines built with the sequencing laboratory CeGaT, with real-world survival data in glioblastoma.
Also called: MVZ Tübingen
Overview
The oncology and haematology practice at MVZ Tübingen offers personalised cancer therapy and advanced diagnostics, including personalised peptide vaccines developed in collaboration with CeGaT; Future of Cancer Care Today notes real-world survival data in glioblastoma and lists it as patient-bookable in Germany.
Location
Tübingen, DE
Type
hospital
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#495 · 6 points (0 Newsweek + 0 NCI + 6 from 3 linked objects) · ranking
Similar pages
- CompanyUbiVac
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyInvoke Bio
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyJaime Leandro Foundation
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyBelay Diagnostics
Shares Glioma & glioblastoma and the tag fcct-directory.
- InstitutionHouston Methodist Center for RNA Therapeutics
Shares Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
- CompanyKiyatec
Shares Glioma & glioblastoma and the tag fcct-directory.
- CompanyDiakonos Oncology
Shares Glioma & glioblastoma and the tag fcct-directory.
- CompanyCureVac
Shares Personalised neoantigen (mRNA) vaccines, Glioma & glioblastoma.